Starling Oncology annual net debt
2020
2021
2022
2023
2024
2025
Starling Oncology Net Debt Growth & History (STLN)
Starling Oncology's net debt was $70.2M for fiscal 2025.
View full Starling Oncology company overviewStarling Oncology annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $70.2M | −$3.4M | −4.62% |
| 2024 | 2024-12-31 | $73.6M | −$12.7M | −14.76% |
| 2023 | 2023-12-31 | $86.3M | −$8.1M | −8.56% |
| 2022 | 2022-12-31 | $94.4M | $209.3M | — |
| 2021 | 2021-12-31 | −$114.9M | −$126.1M | — |
| 2020 | 2020-12-31 | $11.2M | — | — |
Starling Oncology quarterly net debt
Q4.20
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $63.4M | −$9.5M | −13.05% |
| Q1 2026 | 2026-03-31 | $74.6M | $12.0M | +19.11% |
| Q4 2025 | 2025-12-31 | $70.2M | −$3.4M | −4.62% |
| Q3 2025 | 2025-09-30 | $76.0M | $306,000 | +0.40% |
| Q2 2025 | 2025-06-30 | $72.9M | −$11.8M | −13.88% |
| Q1 2025 | 2025-03-31 | $62.7M | −$21.3M | −25.33% |
| Q4 2024 | 2024-12-31 | $73.6M | −$12.7M | −14.76% |
| Q3 2024 | 2024-09-30 | $75.7M | −$14.3M | −15.90% |
| Q2 2024 | 2024-06-30 | $84.7M | −$2.9M | −3.31% |
| Q1 2024 | 2024-03-31 | $83.9M | −$11.1M | −11.68% |
| Q4 2023 | 2023-12-31 | $86.3M | −$8.1M | −8.56% |
| Q3 2023 | 2023-09-30 | $90.0M | $45.1M | +100.38% |
| Q2 2023 | 2023-06-30 | $87.6M | $132.6M | — |
| Q1 2023 | 2023-03-31 | $95.0M | $171.7M | — |
| Q4 2022 | 2022-12-31 | $94.4M | $209.3M | — |
| Q3 2022 | 2022-09-30 | $44.9M | — | — |
| Q2 2022 | 2022-06-30 | −$45.0M | — | — |
| Q1 2022 | 2022-03-31 | −$76.7M | — | — |
| Q4 2021 | 2021-12-31 | −$114.9M | −$126.1M | — |
| Q4 2020 | 2020-12-31 | $11.2M | — | — |
Starling Oncology net debt trends
Over the last five fiscal years, Starling Oncology's net debt increased from $11.2M to $70.2M, a change of $59.0M. The latest reported quarter, Q2 2026, shows $63.4M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Starling Oncology source filings ↗